Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study [version 3; peer review: 2 approved, 1 approved with reservations]

Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study [version 3; peer review: 2 approved, 1 approved with reservations]

Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. Par...

Full description

Bibliographic Details
Main Authors: Borimas Hanboonkunupakarn, Mayfong Mayxay, Carlo Perrone, Elizabeth A. Ashley, Hannah Chase, Nicholas J. White, William Schilling, Nipaphan Kanthawang, Piyush Dahal, Daranee Intralawan, Supalert Nedsuwan, Vimalay Souvong, Abhilasha Karkey, Summita Udas Shakya, Phaik Yeong Cheah, Hien Tran Minh, Surendra Uranw, James J. Callery, Sanjib Kumar Sharma, Charles Woodrow, Souphaphone Vannachione, Mary Chambers
Format: Article
Language:English
Published: Wellcome 2022-12-01
Series:Wellcome Open Research
Subjects:
Good participatory practice
public engagement
Coronavirus Disease 2019 (COVID-19)
prevention
clinical trials
bioethics
eng
Online Access:https://wellcomeopenresearch.org/articles/6-216/v3

Internet

https://wellcomeopenresearch.org/articles/6-216/v3

Similar Items